|
HNRNPK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.781900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.430100E-02 |
| Normal-vs-Stage2 |
1.145970E-02 |
| Normal-vs-Stage3 |
1.67500000003429E-06 |
| Normal-vs-Stage4 |
1.50868999999609E-05 |
| Stage1-vs-Stage2 |
1.652410E-01 |
| Stage1-vs-Stage3 |
5.83650000000047E-05 |
| Stage1-vs-Stage4 |
3.401100E-04 |
| Stage2-vs-Stage3 |
1.658750E-01 |
| Stage2-vs-Stage4 |
1.854650E-01 |
| Stage3-vs-Stage4 |
9.723400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.980200E-04 |
| Normal-vs-AfricanAmerican |
1.499680E-03 |
| Normal-vs-Asian |
7.637600E-01 |
| Caucasian-vs-AfricanAmerican |
5.011800E-01 |
| Caucasian-vs-Asian |
3.432400E-01 |
| AfricanAmerican-vs-Asian |
2.438800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84005999999126E-05 |
| Normal-vs-Female |
5.855900E-02 |
| Male-vs-Female |
1.397030E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.470200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.401300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.820900E-04 |
| Normal-vs-Age(81-100Yrs) |
6.199200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.334400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.624800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.207800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.069400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.586400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.378400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.784610E-01 |
| Normal-vs-Grade 2 |
1.292380E-01 |
| Normal-vs-Grade 3 |
4.21870000000268E-06 |
| Normal-vs-Grade 4 |
4.2179999493186E-09 |
| Grade 1-vs-Grade 2 |
3.996300E-02 |
| Grade 1-vs-Grade 3 |
4.021000E-04 |
| Grade 1-vs-Grade 4 |
3.12729999996098E-06 |
| Grade 2-vs-Grade 3 |
3.57090000000504E-05 |
| Grade 2-vs-Grade 4 |
1.5187999968802E-08 |
| Grade 3-vs-Grade 4 |
8.856000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.231600E-01 |
| Normal-vs-ccB subtype |
1.20099999945111E-08 |
| ccA subtype-vs-ccB subtype |
2.38697950294409E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.830200E-04 |
| Normal-vs-N1 |
2.564600E-03 |
| N0-vs-N1 |
1.800640E-01 |
|
|
